- Stunning entry in the market of shares of Supriya Lifescience
- Listed on BSE at Rs 425 with 55% premium
- Its shares were listed on NSE at Rs 421.
- The company’s 700 crore IPO was opened on 16 December
The shares of Supriya Lifescience had a banging entry in the stock market today. On BSE, it was listed at Rs 425 with a premium of 55.11 per cent. Its issue price was Rs 274. At the same time, its listing on NSE was done at Rs 421. This has given good returns to the investors year after year.
The Rs 700-crore IPO of API maker Supriya Lifesciences opened on December 16 and closed on December 20. It received nearly 72 times the bids. It was completely filled in a few hours on the very first day. In this 1,45,28,299 shares were put up for sale while bids were received for a total of 1,03,89,57,138 shares.
This cryptocurrency overtakes bitcoin in ‘joke’, most discussed in 2021
Supriya Lifesciences is one of the largest Indian companies in the manufacturing and supply of active pharmaceutical components. The money raised through the IPO will be used to meet capital expenditure requirements, repay loans and for general corporate purposes. Supriya Lifesciences is a leading Indian manufacturer and supplier of leading pharmaceutical chemicals (APIs). The main emphasis of the company is on R&D. ICICI Securities and Axis Capital were appointed as merchant bankers to advise the company on the IPO.
You can read the stories of Economic Times for excellent articles related to more than 20 sectors of business and in-depth information related to the industry. Click here to read the informative information of Economic Times.